
Microsoft’s multibillion-dollar deal to build customized versions of its HoloLens goggles for the US Army is moving forward, one year after the Senate considered freezing half the contract, reported Bloomberg.
The deal, initially unveiled three years ago, is now worth as much as $21.9 billion over 10 years, according to Microsoft. The agreement runs for an initial five years, with an option to add another five years. The software maker will manufacture the augmented-reality devices in the US The Army announced the contract Wednesday on its website.
The initial commitment includes outfitting the Army’s entire Close Combat Force, more than 120,000 soldiers, Microsoft said. The contract also includes some Azure cloud services.
The program, known as the Integrated Visual Augmentation System, or IVAS, aims to develop a “heads-up display” for US ground forces, similar to those fighter pilots use in the cockpit. The system would let commanders project information onto a visor in front of a soldier’s face, and would include other features such as night vision. In October 2018, the US Army awarded Microsoft a $480 million contract to adapt its HoloLens AR headset, a set of goggles that overlay holograms on top of a user’s field of view, for the program.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Federal Court to Hear Case on Trump’s Firing of FTC Democrats
May 20, 2025 by
CPI
UK Government Suffers Third Successive Defeat on Data (Use and Access) Bill
May 20, 2025 by
CPI
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Brazil’s Antitrust Watchdog Expected to Approve Pet Retail Merger Without Conditions
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas